Could oxime HI-6 really be considered as "broad-spectrum" antidote? Article

Kuca, Kamil, Musilek, Kamil, Jun, Daniel et al. (2009). Could oxime HI-6 really be considered as "broad-spectrum" antidote? . 7(3), 143-149. 10.32725/jab.2009.016

Open Access

cited authors

  • Kuca, Kamil; Musilek, Kamil; Jun, Daniel; Pohanka, Miroslav; Karasova, Jana Zd'arova; Novotny, Ladislav; Musilova, Lucie

sustainable development goals

authors

publication date

  • January 1, 2009

webpage

keywords

  • BISPYRIDINIUM OXIMES
  • CHOLINESTERASE REACTIVATOR
  • CURRENTLY AVAILABLE OXIMES
  • CYCLOSARIN-INHIBITED ACHE
  • HI-6
  • IN-VITRO REACTIVATION
  • Life Sciences & Biomedicine
  • Medicine, Research & Experimental
  • NERVE AGENTS
  • ORGANOPHOSPHATE PARAOXON
  • PYRIDINIUM OXIMES
  • Pharmacology & Pharmacy
  • RAT-BRAIN ACETYLCHOLINESTERASE
  • Research & Experimental Medicine
  • Science & Technology
  • THERAPEUTIC-EFFICACY
  • acetylcholinesterase
  • broad-spectrum
  • nerve agent
  • oxime
  • pesticide
  • reactivator

Digital Object Identifier (DOI)

publisher

  • UNIV SOUTH BOHEMIA

start page

  • 143

end page

  • 149

volume

  • 7

issue

  • 3